2-Bromo-3,4,6-trifluorobenzene sulfonamide
|
- $98 - $2074
- Product name: 2-Bromo-3,4,6-trifluorobenzene sulfonamide
- CAS: 1208077-62-6
- MF: C6H3BrF3NO2S
- MW: 290.06
- EINECS:
- MDL Number:MFCD12026265
- Synonyms:2-Bromo-3,4,6-trifluorobenzene sulfonamide;Benzenesulfonamide, 2-bromo-3,4,6-trifluoro-
4 prices
Selected condition:
Brand
- aablocks
- Crysdot
Package
- 100mg
- 1g
- 5g
- Manufactureraablocks
- Product numberAA01FB3F
- Product description2-Bromo-3,4,6-trifluorobenzenesulfonamide 90%
- Packaging100mg
- Price$98
- Updated2026-05-30
- Buy
- Manufactureraablocks
- Product numberAA01FB3F
- Product description2-Bromo-3,4,6-trifluorobenzenesulfonamide 90%
- Packaging1g
- Price$442
- Updated2026-05-30
- Buy
- Manufactureraablocks
- Product numberAA01FB3F
- Product description2-Bromo-3,4,6-trifluorobenzenesulfonamide 90%
- Packaging5g
- Price$2074
- Updated2026-05-30
- Buy
- ManufacturerCrysdot
- Product numberCD12173733
- Product description2-Bromo-3,4,6-trifluorobenzenesulfonamide 97%
- Packaging5g
- Price$1782
- Updated2026-05-27
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| aablocks | AA01FB3F | 2-Bromo-3,4,6-trifluorobenzenesulfonamide 90% | 100mg | $98 | 2026-05-30 | Buy |
| aablocks | AA01FB3F | 2-Bromo-3,4,6-trifluorobenzenesulfonamide 90% | 1g | $442 | 2026-05-30 | Buy |
| aablocks | AA01FB3F | 2-Bromo-3,4,6-trifluorobenzenesulfonamide 90% | 5g | $2074 | 2026-05-30 | Buy |
| Crysdot | CD12173733 | 2-Bromo-3,4,6-trifluorobenzenesulfonamide 97% | 5g | $1782 | 2026-05-27 | Buy |
Properties
Boiling point :349.3±52.0 °C(Predicted)
Density :1.970±0.06 g/cm3(Predicted)
pka :8.98±0.60(Predicted)
Density :1.970±0.06 g/cm3(Predicted)
pka :8.98±0.60(Predicted)
Safety Information
| Symbol(GHS): |
|
||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Signal word: | Danger | ||||||||||||||||||||||||||||
| Hazard statements: |
|
||||||||||||||||||||||||||||
| Precautionary statements: |
|




